23andMe Faces Board Resignation Amid Private Takeover Move by CEO

23andMe Faces Board Resignation Amid Private Takeover Move by CEO

1 minute read
Updated 6 months ago

Board Resignation and CEO's Response

All independent directors of resigned, citing a lack of a solid proposal from CEO for taking the company private and a difference in strategic direction.

Anne Wojcicki expressed surprise and disappointment over the resignations, reiterating her belief that taking 23andMe private would be beneficial for its long-term success.

Financial Struggles and Legal Issues

Since going public in 2021, 23andMe has struggled with profitability, reporting significant losses and a drastic drop in stock price.

The company agreed to a $30 million settlement in a class-action lawsuit over a data breach, adding to its financial and operational challenges.
This is a beta feature. We cannot guarantee the accuracy or quality of responses.